US › Healthcare

Jaguar Animal Health Inc (JAGX)

US · Healthcare · Biotechnology

$1.000.00%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$20.3M
Revenue YoY
+815.6%
Net profit
$8.8M
Profit YoY
+184.6%
EPS
$-219.80
EPS estimate
$-177.80
Net margin
43.7%

EPS came in at -219.80 against a street estimate of -177.80 — a miss of 23.6%.

Key statistics

Market cap
$4.9M
Forward P/E
200.0
P/B
1.62
Book value
$-38.12
EPS (TTM)
$-695.50
52-week high
$92.75
52-week low
$0.91
50-day MA
$2.39
200-day MA
$24.04
Beta
-0.05

Analyst view

Analysts rate Jaguar Animal Health Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $262.50.

Shareholding

Insiders
0.63%
Institutions
0.15%

Largest institutional holders

FundStake
UBS Group AG0.49%
Geode Capital Management, LLC0.48%
SBI Securities Co Ltd0.01%
Tower Research Capital LLC0.01%
Royal Bank of Canada0.00%
LEONTEQ SECURITIES AG0.00%
International Assets Investment Management, LLC0.00%
BlackRock Inc0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Jaguar Animal Health Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.